Clinical trial
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes
NCT01219465 is registered in ClinicalTrials.gov with Qingdao University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes
- Lead sponsor
- Qingdao University
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 30, 2010
- Completion date
- December 31, 2012
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, diabetes mellitus, type 1, mesenchymal stem cells, umbilical cord